ART VIVANT (7523) FY2026 Q3 Earnings Report

Quick View

Executive Summary

The key highlight of the cumulative Q3 results for FY2026 was a significant improvement in profitability, driven by profit growth that exceeded revenue growth. Revenue was ¥8.85B (+9.3% YoY), Operating Income was ¥2.55B (+32.8%), Ordinary Income was ¥2.54B (+14.8%), and Net Income was ¥1.63B (+11.2%). The Operating Margin was 28.8%, representing a substantial expansion from the same period of the previous year. Revenue and profit growth in the art-related business, together with the high profitability of the financial services business, drove overall earnings growth.

Factors Affecting Results

【Revenue】Revenue was ¥8.85B, representing a +9.3% YoY increase. The core art-related business grew to ¥6.87B (+12.4%), driving overall company growth, while the financial services business remained solid at ¥1.31B (+4.1%). In contrast, the health industry business declined to ¥0.70B (▲7.5%).

【Profit and Loss】Operating Income increased to ¥2.55B (+32.8%), expanding at a pace substantially exceeding revenue growth, and the Operating Margin was 28.8%. The high Gross Margin of 74.0% absorbed SG&A expenses, which represented 45.2% of revenue, resulting in strong operating leverage. Ordinary Income was ¥2.54B (+14.8%), slightly slower than Operating Income growth, while Net Income remained at ¥1.63B (+11.2%). This divergence was primarily attributable to the recognition of an extraordinary loss of ¥0.24B, which compressed Profit Before Tax to ¥2.30B. Overall, the company achieved both revenue and profit growth, with the notable feature that profit growth continued to exceed revenue growth.

Segment Analysis

The art-related business is the core business, with Revenue of ¥6.87B (+12.4%) and Operating Income of ¥1.55B (+47.6%), accounting for approximately 77.6% of total company revenue and approximately 60.8% of Operating Income. Its margin improved from the previous year to 22.6%. The financial services business recorded Revenue of ¥1.31B (+4.1%) and Operating Income of ¥0.89B (+16.8%). Although growth was moderate, its margin was exceptionally high at 69.2%, making it an important source of earnings in terms of profit composition. The health industry business declined in revenue to ¥0.70B (▲7.5%) and recorded Operating Income of ¥0.07B (+2.0%). The decline in this business is a factor weakening growth diversification within the business portfolio.

Key Financial Indicators

【Profitability】The Operating Margin was 28.8% and the Net Profit Margin was 18.5%, both high levels, with the Operating Margin improving substantially from approximately 19.2% in the same period of the previous year. 【Cash Quality】Accounts receivable of ¥17.81B and inventories of ¥6.87B accounted for approximately 67.5% in total of total assets, constraining asset efficiency. 【Investment Efficiency】ROE of 10.1% was supported by the high Net Profit Margin of 18.5%, while the low Total Asset Turnover indicates room for improvement in asset efficiency. Financial leverage was 2.26x. 【Financial Soundness】Although surface-level liquidity was sound, with an Equity Ratio of 44.2% and a Current Ratio of 180.0%, cash and deposits of ¥7.26B were below short-term borrowings of ¥7.99B, resulting in a cash-to-short-term liabilities ratio of only 0.91x.

Cash Flow Analysis

Cash flow statement figures have not been disclosed; therefore, funding trends are assessed based on movements in the balance sheet. Cash and deposits increased to ¥7.26B from ¥5.75B in the previous year, while accounts receivable expanded to ¥17.81B from ¥16.01B in the previous year, representing approximately 48.7% of total assets. Inventories also remained high at ¥6.87B, suggesting that working capital expansion may be preceding profit growth. Short-term borrowings were ¥7.99B, while interest-bearing debt, including a portion of long-term borrowings, accounted for approximately 26.1% of total assets, indicating a relatively high dependence on short-term borrowings in the funding structure. Confirming the status of cash collection from operating activities relative to profit growth is an important focus in evaluating earnings quality.

Earnings Quality

Operating Income increased substantially by +32.8% YoY, but the growth rate decelerated further down the income statement, with Ordinary Income increasing by +14.8% and Net Income by +11.2%. This divergence was primarily attributable to non-recurring factors, namely the recognition of an extraordinary loss of ¥0.24B. Non-operating income and expenses were nearly offset, with income of ¥0.07B against expenses of ¥0.09B; interest expense of ¥0.08B was the principal expense item. Comprehensive Income was ¥1.68B, nearly in line with Net Income of ¥1.63B, indicating that the divergence attributable to other comprehensive income, such as valuation differences on securities, was limited. Meanwhile, the expansion of accounts receivable and inventories suggests that cash collection may be lagging behind accounting earnings. From an accrual perspective, it cannot be concluded that the increase in Operating Income directly translates into improved cash generation capacity.

Earnings Forecast and Guidance

The cumulative Q3 progress rates against the Full-Year forecast were 80.4% for Revenue, 121.5% for Operating Income, 123.7% for Ordinary Income, and 136.1% for Net Income, with the profit items already exceeding the Full-Year forecasts. In particular, cumulative Net Income of ¥1.63B substantially exceeded the Full-Year Net Income forecast of ¥1.20B, suggesting that the Full-Year Ordinary Income forecast of ¥2.05B (▲9.6% YoY) may have been set conservatively. Whether this outperformance was attributable to temporary sales trends in the art-related business or structural improvements in profitability should be confirmed through results in subsequent quarters.

Shareholder Returns

The annual dividend forecast is ¥60 (¥30 for Q2 and an assumed ¥30 year-end dividend), and the Payout Ratio is low at 16.8% of Net Income. Cumulative Q3 Net Income of ¥1.63B has already exceeded the Full-Year Net Income forecast of ¥1.20B, indicating a light dividend burden relative to the current earnings level. No share repurchase has been disclosed, and shareholder returns should therefore be evaluated based on the Payout Ratio.

Risk Factors

1. Short-term funding risk: Short-term borrowings are ¥7.99B, compared with cash and deposits of ¥7.26B, resulting in a cash-to-short-term liabilities ratio of only 0.91x. Changes in refinancing terms or the lending stance of financial institutions could affect liquidity management.

2. Working capital retention risk: Accounts receivable of ¥17.81B and inventories of ¥6.87B account for approximately 67.5% of total assets, and delays in collection and monetization could widen the gap between profit and cash generation.

3. Business portfolio concentration risk: Approximately 60.8% of Operating Income is dependent on the art-related business. Although the financial services business also has a high margin of 69.2%, its scale is small. The decline in the health industry business is weakening diversification benefits, leaving the overall results vulnerable to fluctuations in demand for the core businesses.

Industry Benchmark (For Reference; Compiled by the Company)

Industry Benchmark (retail)

Profitability and Returns

The company demonstrates profitability substantially above the industry median and ranks among the top performers within the industry.

Growth and Capital Efficiency

The Revenue Growth Rate is also close to the upper bound of the industry IQR, placing the company among the industry leaders in terms of growth.

※Source: Compiled by the Company

Key Takeaways from the Financial Results

1. The Operating Margin expanded substantially from the same period of the previous year, confirming high operating leverage supported by a Gross Margin of 74.0%. The gap between the +9.3% revenue growth rate and the +32.8% Operating Income growth rate indicates greater efficiency in the cost structure.

2. Profit progress against the Full-Year forecast was substantially ahead, with profit items exceeding 120% compared with Revenue progress of 80.4%, suggesting that the assumptions underlying the Full-Year forecast may be conservative. It is important to determine whether future outperformance is attributable to temporary or ongoing factors.

3. Accounts receivable and inventories account for approximately 67.5% of total assets, with working capital expansion preceding the pace of profit growth. The relationship between accounting profit growth and cash collection is an important point to monitor when evaluating the quality of the financial results.

---

This report is an automatically generated earnings analysis document created by AI based on XBRL earnings release data. It does not constitute a recommendation to invest in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly available earnings data. Investment decisions should be made at your own responsibility, after consulting with professionals as necessary.

---End of Report---

---

AI Financial Analysis

Executive Summary

FY2026 Q3 performance was strong at the operating level, with sales growth translating into substantial margin expansion, although the balance sheet remains highly working-capital intensive and reliant on short-term funding. Cumulative Q3 revenue increased 9.3% YoY to ¥8.85bn. Operating income rose 32.8% to ¥2.55bn, materially outpacing revenue growth. Net income increased 11.2% to ¥1.63bn. The gross margin improved by approximately 280bp YoY to 74.0%, reflecting a favorable profitability mix and/or pricing outcome. The operating margin expanded by approximately 510bp to 28.8% from 23.7% in the prior-year period. SG&A increased only 3.9% YoY to ¥4.00bn, versus 9.3% revenue growth, reducing the SG&A-to-sales ratio by roughly 230bp to 45.2%. The Art-related business was the principal earnings driver, generating ¥6.87bn of sales and ¥1.55bn of segment profit. Financial Services remained the highest-margin segment, with a 69.2% segment-profit margin and ¥0.89bn of segment profit. Health Industry segment sales declined 7.5% YoY, although segment profit rose modestly to ¥0.70bn. Ordinary income grew more slowly than operating income, at 14.8% YoY, because net non-operating income declined sharply from the prior-year period. Net income growth was further constrained by a ¥2.36bn extraordinary loss, principally including a ¥2.15bn loss on sale of investment securities. The effective tax rate was 29.1%, and the tax burden of 0.709 was within a normal range. Annualized ROE was 13.5%, which is solid but remains below the 15% level generally viewed as excellent. The company has already exceeded its full-year operating-income forecast by Q3, reaching 121.5% of guidance, indicating that the formal forecast appears conservative or that a meaningful Q4 earnings decline is embedded. Liquidity ratios are healthy, but receivables and inventories account for 67.5% of total assets, making cash conversion and the quality of these balances central considerations. The 84% short-term debt mix creates refinancing exposure despite strong interest coverage. The ¥60 full-year DPS forecast implies a prospective dividend payout ratio of approximately 45.5% based on forecast EPS, which appears manageable from an accounting-profit perspective.

Profitability Analysis

The annualized DuPont ROE of 13.5% is decomposed into a 18.5% net profit margin, 0.322x asset turnover, and 2.26x financial leverage. The strongest component is profitability: the 18.5% net margin is well above the 10% benchmark for excellent profitability, while the 28.8% EBIT margin also exceeds the 15% excellent benchmark. Asset turnover is comparatively low, reflecting the company’s large receivable and inventory balances relative to sales. Financial leverage is moderate rather than aggressive, with a 1.26x debt-to-equity ratio, although total assets are funded with liabilities equal to 55.8% of assets. The principal YoY improvement was margin expansion rather than balance-sheet efficiency. Gross profit increased 13.6% YoY to ¥6.55bn, faster than revenue growth of 9.3%, lifting gross margin to 74.0% from approximately 71.2%. Operating income increased 32.8% because SG&A grew only 3.9%, demonstrating favorable operating leverage. Segment performance confirms that the Art-related business was the core business by operating-income contribution: sales rose 12.4% to ¥6.87bn and segment profit rose 47.6% to ¥1.55bn, producing a 22.6% segment margin versus approximately 17.2% a year earlier. Financial Services sales increased 4.1% to ¥1.28bn, while segment profit rose 16.8% to ¥0.89bn and margin improved to 69.2% from approximately 60.6%. Health Industry sales declined 7.5% to ¥0.70bn, but segment profit increased 2.0% to ¥0.70bn, with margin improving to 10.0% from 9.1%. The earnings mix is therefore increasingly supported by high-margin Art-related and Financial Services activities. Interest coverage of 30.74x indicates that current operating profit comfortably covers reported interest expense. However, ordinary income growth of 14.8% lagged operating-income growth because non-operating income was lower YoY, including a much smaller foreign-exchange gain. The ¥2.36bn extraordinary loss reduced the conversion of operating earnings into profit before tax, making the Q3 net-income outcome less representative of underlying operating momentum.

Growth Assessment

Revenue growth of 9.3% was led by the Art-related business, which added approximately ¥0.76bn of sales YoY. Financial Services contributed a further approximately ¥0.05bn of sales growth. Health Industry detracted approximately ¥0.06bn from consolidated sales growth. The earnings trajectory was stronger than the revenue trend, as gross-margin expansion and controlled SG&A generated a 32.8% increase in operating income. The Art-related segment’s 47.6% profit growth indicates that improved unit economics and operating leverage were meaningful contributors. Financial Services also enhanced consolidated profit quality through 16.8% segment-profit growth on only 4.1% sales growth. Health Industry remains a smaller contributor and its sales contraction makes it the weakest operating growth area. The Q3 cumulative revenue progress rate is 80.4% of the ¥11.0bn full-year forecast, 5.4 percentage points above the standard 75% Q3 run rate. Operating income has reached 121.5% of the ¥2.10bn full-year forecast, 46.5 percentage points above the standard run rate. Ordinary income has reached 123.7% of guidance, and net income attributable to owners has reached 136.1% of the ¥1.20bn forecast. The variance versus guidance is material and suggests a conservative plan, potential seasonality, or an expected Q4 reduction in profitability. The full-year forecast calls for only 2.5% revenue growth and a 0.7% operating-income decline, which contrasts sharply with Q3 cumulative performance. The sustainability of current margins should be evaluated against Art-related sales execution and Financial Services credit performance, because these two segments generated nearly all segment profit.

Financial Health

The current ratio of 180.0% and quick ratio of 142.7% indicate adequate near-term balance-sheet liquidity. Working capital was ¥14.75bn at Q3. Cash and deposits increased 26.2% YoY to ¥7.26bn, strengthening the immediate liquidity buffer. Debt-to-equity was 1.26x, below the 2.0x level associated with aggressive leverage. Debt-to-capital was 37.1%, remaining just inside the sub-40% investment-grade reference range. Interest-bearing debt totaled ¥9.56bn, equivalent to approximately 59.1% of equity. Short-term loans were ¥7.99bn, while the current portion of long-term loans was ¥1.38bn; consequently, debt maturities are concentrated in the near term. The short-term debt ratio of 83.5% is a refinancing-risk alert because a large portion of borrowings requires regular rollover. Cash covered 0.91x of short-term loans, so cash alone does not fully cover these borrowings. Current assets exceed current liabilities, mitigating the maturity mismatch at an aggregate level, but a large part of current assets is tied up in receivables and inventory rather than cash. Accounts receivable of ¥17.81bn represented 48.7% of total assets, and inventories of ¥6.87bn represented 18.8% of total assets. Advances received increased to ¥4.07bn from ¥2.75bn, providing a partial operating funding source. Long-term loans declined 38.1% YoY to ¥1.57bn, reducing longer-dated leverage. Investment securities declined 64.5% YoY to ¥0.83bn, consistent with portfolio monetization and linked to the large loss recognized on sale of investment securities. Asset retirement obligations totaled ¥2.08bn and should be incorporated into assessments of fixed-location and closure-related obligations. The refinancing alert is particularly relevant because the company’s liquidity depends on continued collections from a substantial receivable base and access to short-term borrowing markets.

Notable B/S Changes

Investment securities: -¥1.51bn (-64.5%) to ¥0.83bn - substantial portfolio reduction; the period also included a ¥2.15bn loss on sale of investment securities, increasing below-the-line earnings volatility. Cash and deposits: +¥1.51bn (+26.2%) to ¥7.26bn - improves liquidity, although cash remains below short-term loans of ¥7.99bn. Long-term loans: -¥0.97bn (-38.1%) to ¥1.57bn - reduces longer-term leverage but contributes to a funding structure concentrated in short-term borrowings. Accounts receivable: +¥1.80bn (+11.3%) to ¥17.81bn - growth exceeded the 9.3% increase in revenue and reinforces the importance of collection quality. Advances received: +¥1.32bn (+47.9%) to ¥4.07bn - provides an operating funding source and partly offsets the working-capital burden. Total equity: +¥0.87bn (+5.7%) to ¥16.18bn - mainly supported by retained earnings growth, strengthening book value per share to approximately ¥1,768.

Cash Flow Quality

Operating cash-flow and free-cash-flow figures are not reported in the provided financial data, so cash conversion cannot be quantified directly. Earnings quality should therefore be assessed primarily through working-capital intensity and the composition of reported profit. The company reported ¥1.63bn of net income, but receivables were ¥17.81bn and inventories were ¥6.87bn at period-end. The quality-alert DSO of 551 days is exceptionally high relative to the 60-day reference threshold. This indicates that a large proportion of reported sales remains uncollected for an extended period, raising counterparty-credit, collection-timing, and funding requirements. The high DSO can be structurally influenced by the company’s finance-related activities and transaction model, but it remains material because receivables are nearly half of total assets. The quality-alert DIO of 832 days, with an additional reported alert of 818 days, is also far above retail and specialty-goods benchmarks. Such inventory duration is consistent with art and high-value merchandise having slow sales cycles, but it heightens valuation, obsolescence, markdown, and liquidity risks if demand weakens. The reported cash conversion cycle of 1,334 days is the most significant cash-flow-quality concern. A long cash conversion cycle means earnings growth can require substantial balance-sheet funding even when accounting margins are high. Finished goods declined modestly YoY to ¥6.87bn, which is constructive, but inventory remains large in absolute terms. Receivables increased 11.3% YoY, faster than revenue growth of 9.3%, which warrants close monitoring of collection quality. The ¥2.15bn loss on sale of investment securities is non-recurring and reduced pre-tax income; it does not detract from operating income but demonstrates that below-the-line items can materially affect statutory earnings. Conversely, the underlying operating-profit increase was driven by gross-margin expansion and SG&A discipline rather than a non-operating gain. Cash flow available for dividends, debt reduction, and inventory investment should be evaluated through future operating cash-flow disclosures given the extended cash-conversion cycle.

Dividend Sustainability

The company paid or declared a Q2 DPS of ¥30.00. The calculated interim payout ratio against Q3 cumulative net income was 16.8%, indicating a low distribution of earnings at this stage of the fiscal year. The full-year forecast DPS is ¥60.00. Based on forecast EPS of ¥131.77, the prospective full-year dividend payout ratio is approximately 45.5%. This is below the 60% benchmark generally associated with a sustainable dividend policy. Q3 cumulative EPS of ¥179.23 already exceeds full-year forecast EPS, so actual full-year payout could be lower than 45.5% if earnings remain above plan. Retained earnings totaled ¥12.26bn, providing a substantial accounting equity cushion relative to the anticipated cash dividend. Dividend sustainability nevertheless depends on cash realization because the business carries high receivables, high inventories, and a very long cash conversion cycle. The concentration of debt in short-term borrowings means internal cash may also be needed for refinancing flexibility and working-capital funding. No share buyback is identified in the provided data; accordingly, the analysis is limited to the dividend payout ratio rather than total return ratio. The current dividend framework appears supportable based on forecast accounting earnings, while collection performance and inventory monetization remain the key determinants of cash-backed sustainability.

Risk Assessment

Business risks include Art-related demand risk: the core Art-related business generated ¥6.87bn of sales and ¥1.55bn of segment profit; a slowdown in discretionary demand or deterioration in sales productivity would have an outsized effect on consolidated earnings., Inventory valuation and liquidity risk: quality-alert inventory days of 832 days, and separately 818 days, indicate very slow inventory conversion. This may be partly structural for high-value art and specialty goods, but it increases exposure to markdowns, impairment, and cash tied up in stock., Receivable collection and customer-credit risk: DSO of 551 days is far above the 60-day alert threshold. The balance is material at ¥17.81bn, or 48.7% of total assets, and requires sustained collection performance., Financial Services performance risk: while the segment produced the highest margin at 69.2%, its earnings depend on customer repayment behavior, credit costs, and funding conditions., Health Industry execution risk: segment revenue declined 7.5% YoY to ¥0.70bn, indicating weaker demand momentum than the group..

Financial risks include Refinancing risk: 83.5% of interest-bearing debt is short term, materially above the 40% alert threshold. This structure requires regular refinancing and creates sensitivity to lender appetite and funding rates., Cash coverage risk: cash and deposits of ¥7.26bn covered only 0.91x of short-term loans, meaning the company depends on collections, operating cash inflow, and/or continued debt rollover., Long cash conversion cycle: the 1,334-day quality-alert cash conversion cycle implies substantial funding needs and can weaken cash generation despite high reported margins., Below-the-line volatility: a ¥2.15bn loss on sale of investment securities was the principal component of ¥2.36bn extraordinary loss, illustrating potential volatility in statutory profit from asset transactions., Interest-rate sensitivity: interest expense rose to ¥0.83bn from ¥0.63bn YoY, although current interest coverage remains strong at 30.74x..

Key concerns include Highest priority is the combination of unusually long receivable and inventory days with a short-term debt-heavy funding structure., The DSO and DIO alerts are structurally relevant to the company’s business model, but their scale means that a modest deterioration in collections or inventory realization could have a high liquidity impact., Operating-profit momentum is strong, but the Q3 result exceeds full-year guidance by a wide margin; the degree to which this reflects conservatism versus expected Q4 seasonality is important for earnings visibility., The loss on sale of investment securities reduced pre-tax income and should be distinguished from recurring operating performance., Asset retirement obligations of ¥2.08bn and store-closure losses should be monitored as fixed-location commitments within the operating model..

Investment Implications

Key takeaways include Revenue increased 9.3% YoY and operating income increased 32.8% YoY, supported by a 510bp operating-margin expansion to 28.8%., Art-related business is the core profit engine, while Financial Services delivers the highest segment margin at 69.2%., The annualized 13.5% ROE is driven by strong profitability and moderate leverage, but asset turnover is constrained by a large working-capital base., Liquidity ratios are sound, yet short-term debt concentration and cash coverage below 1.0x make refinancing and collection performance critical., The ¥60 forecast DPS implies an approximately 45.5% forecast payout ratio, which is moderate, subject to cash conversion..

Metrics to watch include Accounts receivable growth, DSO, collection losses, and allowance movements, Inventory balance, inventory days, valuation adjustments, and realized sales velocity, Short-term loan rollover, interest expense, and cash-to-short-term-debt coverage, Art-related segment revenue growth and segment-profit margin, Financial Services segment credit performance and segment-profit margin, Whether full-year guidance is revised after Q3 operating income reached 121.5% of the initial forecast, Recurring operating profit versus gains and losses on investment securities.

Regarding relative positioning, The company exhibits specialty-business profitability materially above general retail benchmarks, with a 74.0% gross margin and 28.8% operating margin. Its financial profile is less conservative than a cash-and-carry retailer because receivables and inventory dominate the asset base and the operating cycle is exceptionally long. Strong interest coverage and acceptable current and quick ratios provide near-term support, but the combination of slow asset conversion and short-term debt reliance differentiates its risk profile from businesses with faster cash turnover.